Back to Search
Start Over
Supplementary Figure 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....51104a73acc4f1d97aa5b7882bdde64a
- Full Text :
- https://doi.org/10.1158/0008-5472.22386785